This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2026 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.80% per year. These returns cover a period from January 1, 1988 through August 3, 2026. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View the Zacks #1 Rank List
Zacks News
Is State Street SPDR S&P Health Care Services ETF (XHS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHS
Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)?
by Zacks Equity Research
Sector ETF report for XHS
Is State Street SPDR S&P Health Care Services ETF (XHS) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for XHS
Should You Invest in the State Street SPDR S&P Health Care Services ETF (XHS)?
by Zacks Equity Research
Sector ETF report for XHS
Best ETF Areas of June
by Sanghamitra Saha
Biotech, China, insurance and healthcare ETFs led June gains as strong earnings, AI optimism and easing geopolitical fears lifted markets.
Health Care Services ETF (XHS) Touches a New 52-Week High
by Aparajita Dutta
XHS hits a new 52-week high as healthcare-services stocks gain from steady earnings and defensive investor positioning.
Winners & Losers: The ETF Playbook to Glide Trump's Great Healthcare Plan
by Aparajita Dutta
Trump's Great Healthcare Plan redraws healthcare winners and losers - here's how ETFs like IHE could benefit as middlemen face pressure.
The Zacks Analyst Blog Highlights LLY, EPHE, BBC, HELX, XHS and SURI
by Zacks Equity Research
LLY, EPHE, BBC, HELX, XHS and SURI headline last week's top-performing ETFs as healthcare and biotech outperform a weak broader market.
Best-Performing ETFs of Last Week: Healthcare Rules
by Sanghamitra Saha
Healthcare and biotech led last week's winners, with EPHE, BBC, HELX, XHS and SURI topping ETF gains as markets slid on AI worries and Fed uncertainty.
Is Healthcare Losing the Status of Safe Haven? ETFs in Focus
by Sanghamitra Saha
Healthcare stocks face new risks under Trump, despite their usual defensive reputation.